Disclosure of the Genetic Risk of Alzheimer ’ s Disease : A Rejoinder to Green et al . ’ s Response to Our Critique

@inproceedings{Gordon2010DisclosureOT,
  title={Disclosure of the Genetic Risk of Alzheimer ’ s Disease : A Rejoinder to Green et al . ’ s Response to Our Critique},
  author={Sanford Clark Gordon},
  year={2010}
}
As many as 5.3 million people in the United States are estimated to be afflicted by Alzheimer’s disease, with the overall costs of Alzheimer's and other dementias to Medicare, Medicaid and businesses estimated at upwards of $148 billion each year. Issues related to treatment, care, and research into the disease have, understandably, had a high public policy profile and attracted considerable public attention. One such issue is the desirability of genetic testing of relatives of Alzheimer’s… CONTINUE READING